Scholars Central

Conference abstractPublished 12 Sep 2011

Sulphonylureas: Do we need to introspect safety again?

Authors: Devindra Sehra, Sudhish Sehra, Shiv Tej Sehra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Sulphonylureas (SUs) are commonly prescribed medications for type 2 diabetes mellitus (T2DM) worldwide. Diff erences among SUs for kinetic and adenosine triphosphate sensitive potassium (KATP) channels selectivity and consequential extra pancreatic eff ects, though recognized in literature, are not considered by treatment guidelines. Areas Covered: Th e role of SUs in various systems related adverse eff ects have not been well understood. Inconsistencies in literature and lack of clinical trials assessing the long-term eff ects of monotherapy or combination therapy with SUs add to the concern. Th is review provides insights in issues concerning safety of SUs based on literature published between 1980-2011. A comprehensive search was carried out on PubMed, Embase & Cochrane databases using search terms viz. sulphonylureas, sulphonylureas and KATP channels, sulphonylureas & cardiovascular eff ects, sulphonylureas side eff ects etc. Expert Opinion: SUs have been linked to CV events, growth hormone (GH) disorder, malignancy, weight gain and CNS adverse eff ects. Th ese adverse eff ects generally get masked as they are thought to be related to diabetes per se. Th e current article will allow the fraternity to ponder and undertake further research on the ill eff ects of largely prescribed anti-diabetic medication.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Biomarkers & Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Biomarkers & Diagnosis
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Devindra Sehra”
  • BylineArticles whose byline prints “Sudhish Sehra”
  • BylineArticles whose byline prints “Shiv Tej Sehra”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels